RecallDepth
Class I Terminated

Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle), Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD, 21801, NDC 59746-122-06

Company
Jubilant Cadista Pharmaceuticals, Inc.
Recall Initiated
March 8, 2022
Posted
April 6, 2022
Recall Number
D-0767-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
12,174 bottles
Firm Location
Salisbury, MD, United States

Reason for Recall

Labeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE Tablets. The tablets in the bottles are Meclizine Hydrochloride

Distribution

Product was distributed in Arkansas, Florida, North Carolina, South Carolina and Ohio.

Lot / Code Info

Lot # 22P0036, Exp 12/2024

More recalls by Jubilant Cadista Pharmaceuticals, Inc.

View all recalls by this company →

Other recent Class I Drug recalls